RESUMO
Zika virus (ZIKV) infection remains a global public health problem. After the "Public Health Emergencies of International Concern" declared in February 2016, the incidence of new infections by this pathogen has been decreasing in many areas. However, there is still a likely risk that ZIKV will spread to more countries. To date, there is no vaccine or antiviral drug available to prevent or treat Zika virus infection. In the Zika vaccine development, those based on protein subunits are attractive as a non-replicable platform due to their potentially enhanced safety profile to be used in all populations. However, these vaccines frequently require multiple doses and adjuvants to achieve protective immunity. In this study we show the immunological evaluation of new formulations of the recombinant protein ZEC, which combines regions of domain III of the envelope and the capsid from ZIKV. Two nucleotide-based adjuvants were used to enhance the immunity elicited by the vaccine candidate ZEC. ODN 39M or c-di-AMP was incorporated as immunomodulator into the formulations combined with aluminum hydroxide. Following immunizations in immunocompetent BALB/c mice, the formulations stimulated high IgG antibodies. Although the IgG subtypes suggested a predominantly Th1-biased immune response by the formulation including the ODN 39M, cellular immune responses measured by IFNγ secretion from spleen cells after in vitro stimulations were induced by both immunomodulators. These results demonstrate the capacity of both immunomodulators to enhance the immunogenicity of the recombinant subunit ZEC as a vaccine candidate against ZIKV.
RESUMO
Transcription, a critical process in molecular biology, has found many applications in RNA synthesis, including mRNA vaccines and RNA therapeutics. However, current RNA characterization technologies suffer from amplification and enzymatic biases that lead to loss of native information. Here, we introduce a strategy to quantitatively study both transcription and RNA polymerase behaviour by sizing RNA with RNA nanotechnology and nanopores. To begin, we utilize T7 RNA polymerase to transcribe linear DNA lacking termination sequences. Surprisingly, we discover alternative transcription termination in the origin of replication sequence. Next, we employ circular DNA without transcription terminators to perform rolling circle transcription. This allows us to gain valuable insights into the processivity and transcription behaviour of RNA polymerase at the single-molecule level. Our work demonstrates how RNA nanotechnology and nanopores may be used in tandem for the direct and quantitative analysis of RNA transcripts. This methodology provides a promising pathway for accurate RNA structural mapping by enabling the study of full-length RNA transcripts at the single-molecule level.
Assuntos
RNA , Transcrição Gênica , RNA/genética , RNA Polimerases Dirigidas por DNA/genética , RNA Polimerases Dirigidas por DNA/metabolismo , DNA Circular , NanotecnologiaRESUMO
Electrophoretic transport plays a pivotal role in advancing sensing technologies. So far, systematic studies have focused on the translocation of canonical B-form or A-form nucleic acids, while direct RNA analysis is emerging as the new frontier for nanopore sensing and sequencing. Here, we compare the less-explored dynamics of noncanonical RNA:DNA hybrids in electrophoretic transport to the well-researched transport of B-form DNA. Using DNA/RNA nanotechnology and solid-state nanopores, the translocation of RNA:DNA (RD) and DNA:DNA (DD) duplexes was examined. Notably, RD duplexes were found to translocate through nanopores faster than DD duplexes, despite containing the same number of base pairs. Our experiments reveal that RD duplexes present a noncanonical helix, with distinct transport properties from B-form DD molecules. We find that RD and DD molecules, with the same contour length, move with comparable velocity through nanopores. We examined the physical characteristics of both duplex forms using atomic force microscopy, atomistic molecular dynamics simulations, agarose gel electrophoresis, and dynamic light scattering measurements. With the help of coarse-grained and molecular dynamics simulations, we find the effective force per unit length applied by the electric field to a fragment of RD or DD duplex in nanopores with various geometries or shapes to be approximately the same. Our results shed light on the significance of helical form in nucleic acid translocation, with implications for RNA sensing, sequencing, and the molecular understanding of electrophoretic transport.
Assuntos
DNA , Eletroforese , Simulação de Dinâmica Molecular , Nanoporos , RNA , RNA/química , DNA/química , Conformação de Ácido Nucleico , Nanotecnologia/métodosRESUMO
A chimeric protein, formed by two fragments of the conserved nucleocapsid (N) and S2 proteins from SARS-CoV-2, was obtained as a recombinant construct in Escherichia coli. The N fragment belongs to the C-terminal domain whereas the S2 fragment spans the fibre structure in the post-fusion conformation of the spike protein. The resultant protein, named S2NDH, was able to form spherical particles of 10 nm, which forms aggregates upon mixture with the CpG ODN-39M. Both preparations were recognized by positive COVID-19 human sera. The S2NDH + ODN-39M formulation administered by the intranasal route resulted highly immunogenic in Balb/c mice. It induced cross-reactive anti-N humoral immunity in both sera and bronchoalveolar fluids, under a Th1 pattern. The cell-mediated immunity (CMI) was also broad, with positive response even against the N protein of SARS-CoV-1. However, neither neutralizing antibodies (NAb) nor CMI against the S2 region were obtained. As alternative, the RBD protein was included in the formulation as inducer of NAb. Upon evaluation in mice by the intranasal route, a clear adjuvant effect was detected for the S2NDH + ODN-39M preparation over RBD. High levels of NAb were induced against SARS-CoV-2 and SARS-CoV-1. The bivalent formulation S2NDH + ODN-39M + RBD, administered by the intranasal route, constitutes an attractive proposal as booster vaccine of sarbecovirus scope.
RESUMO
HeberNasvac is a recently developed therapeutic vaccine for chronic hepatitis B (CHB) administered by intranasal (IN) and subcutaneous (SC) routes in a 14 days/10 doses schedule. To compare different schedules and routes of immunizations, a group of patients received four different vaccination regimens in a placebo-controlled factorial study. Subsequently, patients were followed for a minimum time of 48 weeks. Samples collected at the end of the follow-up were compared with initial samples. Groups I and II received the product by IN/SC routes, every 14 and 7 days, respectively. Groups III and IV were treated by SC route alone following a 14 and 7 days schedule. A group of 21 CHB patients received the vaccine in four different schedules and eight patients received placebo for a total of 29 patients enrolled. The 61.9% of vaccinees reduced their VL ≥2Log compared with baseline levels and 25% in placebo group. The 47.6% of vaccines reduced HBV levels to undetectable, 25% in placebo. HBeAg loss and seroconversion to anti-HBeAg was only achieved in vaccinees, 4 out of 9 (44.4%), and 40% (8 out of 20) developed anti-HBs response, none in placebo group. Reduction of HBsAg level in ≥1Log was achieved in the 35.0% of vaccinees and in none of the placebo-treated patients. Considering the individual and factorial analysis, significant HBV DNA reduction was detected in groups I and II, immunized by IN/SC routes. A significantly higher proportion of patients reducing VL to ≥2Log was also detected grouping the patients treated by IN/SC routes (G I + II) and grouping those inoculated every 14 days (G I + III), with 72.7% and 63.6%, respectively, compared with the placebo group (25.0%). The patients immunized every 14 days (G I + G III) also reduced the HBsAg levels compared with baseline. In conclusion, after more than 48 weeks of treatment-free follow-up, HeberNasvac-treated patients demonstrated superior responses compared with the placebo group in terms of antiviral and serological responses. The factorial analysis evidenced that the schedule combining the IN route of immunization and the frequency of 14 days resulted in the stronger antiviral and serological responses. Present results support the study of IN-only immunization schedules in future and was consistent with previous results. Long-lasting follow-ups were done to explore histological variables and the progression of serological variables in order to detect late responders. How to cite this article: Freyre FM, Aguiar JA, Cinza Z, et al. Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac. Euroasian J Hepato-Gastroenterol 2023;13(2):73-78.
RESUMO
Introducción: el ameloblastoma uniquístico es considerado una variante del ameloblastoma, con características clínico-radiográficas e histológicas particulares, mostrando un mejor pronóstico que la forma sólida. Objetivo: describir el manejo y procederes de un paciente con ameloblastoma uniquístico intramural (AUIM) en línea media mandibular con énfasis en la reconstrucción tardía y su rehabilitación. Materiales y métodos: se presenta un varón de 18 años con una lesión indolora en la zona anterior de la mandíbula, relacionada con un diente retenido. Radiográficamente, mostraba imagen unilocular, corticalizada, que causaba expansión de las corticales óseas. Se realizó la resección segmental y ajuste de placa de reconstrucción; en un segundo tiempo quirúrgico se colocó injerto óseo autólogo y, posteriormente, se procedió a la rehabilitación con implantes. Discusión: en el artículo se discute la elección del tratamiento basado en el comportamiento biológico del AUIM, así como la necesidad de restablecer la estética y la función después de una cirugía radical.
Background: the unicystic ameloblastoma (UA) is considered a variant of ameloblastoma, with particular clinica-radiographic and histological characteristics, showing a better prognosis than the solid/ multicystic type. Objective: to describe the managing and procedures of a patient with an unicystic ameloblastoma intramural (IMUA) with emphasis in the late reconstruction and rehabilitation. Materials and methods: a case of an 18-year-old male with a painless lesion in the mandibular anterior area, related to an impacted tooth. Radiographically, it showed a unilocular, corticalized image, which caused expansion of the cortical plates, a segmental resection and reconstruction plate placement was performed; in a second surgical time, autologous bone graft was placed and subsequent rehabilitation with implants. Discussion: the article discusses the choice of treatment based on the lesion biological behavior, as well as the need to restore aesthetics and function after radical surgery.
Assuntos
Humanos , Ameloblastoma , Venezuela , Neoplasias Bucais , Implantes Dentários , Reconstrução Mandibular , Reabilitação BucalRESUMO
Objetivo: partiendo de que los anticuerpos preexistentes en la infección secundaria por dengue suprimen la acción de moléculas con acciones antivirales como el óxido nítrico, se determinó el comportamiento de esa molécula en suero de monos Macacus irus inoculados con virus dengue 2 como infección primaria y en monos con una infección secuencial dengue 4-dengue2. Métodos: los niveles de óxido nítrico referidos como niveles de nitritos fueron detectados mediante la reacción de Griess. Resultados: los niveles máximos de óxido nítrico se detectaron en los animales que sufrieron una infección primaria a partir del séptimo día posinoculación, a diferencia de los monos con infección secundaria en que no se obtuvieron niveles mayores de 100 µM. Conclusiones: al parecer existe una asociación entre la infección secundaria y la inhibición de la producción del óxido nítrico.
Objective: To determine the action of nitric Oxide (NO) in serum samples of dengue 2 inoculated Macacus irus monkeys as primary infection and in dengue 4 -dengue 2 inoculated monkeys as secondary infection, taking into account that preexisting antibodies in secondary dengue infection elicit the action of antiviral molecules such as nitric oxide. Methods: NO levels referred as nitrite levels were detected by Griess colorimetric reaction. Results: The highest nitric oxide levels were detected in those animals with primary infection seven days after inoculation monkeys whereas those monkeys with secondary infection did not show NO levels over 100 µM. Conclusions: Our results suggest that there seems to be a relationship between secondary infection and NO production inhibition.